Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the disease. Here, we...
主要な著者: | Sear, CE, Pieper, P, Amaral, M, Romanelli, MM, Costa-Silva, TA, Haugland, MM, Tate, JA, Lago, JHG, Tempone, AG, Anderson, EA |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
American Chemical Society
2020
|
類似資料
-
Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
著者:: Amaral, M, 等
出版事項: (2023) -
Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi
著者:: Ferreira, D, 等
出版事項: (2019) -
Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design.
著者:: de Sousa, FS, 等
出版事項: (2020) -
Synthesis and anti-parasitic activity of dehydrodieugenol B and analogues
著者:: Sear, C
出版事項: (2020) -
Exploring Synthetic Dihydrobenzofuran and Benzofuran Neolignans as Antiprotozoal Agents against <i>Trypanosoma cruzi</i>
著者:: Mariana C. Pagotti, 等
出版事項: (2023-02-01)